Related Experiment Video
Updated: Nov 20, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Application of a prediction model with laboratory indexes in the risk stratification of patients with COVID-19
Jiru Ye1, Xiaoqing Zhang2, Feng Zhu2
1Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China.
Insights
A new prediction model combining laboratory indexes effectively stratifies COVID-19 patients by severity. This model, using red blood cell count, high-sensitivity C-reactive protein (hsCRP), and procalcitonin (PCT), shows promise for clinical risk assessment.
Area of Science:
- Clinical Medicine
- Infectious Diseases
- Biomarkers
Background:
- Accurate risk stratification is crucial for managing Coronavirus Disease 2019 (COVID-19) patients.
- Identifying reliable laboratory predictors for COVID-19 severity is essential for timely clinical intervention.
Purpose of the Study:
- To establish and validate a prediction model using combined laboratory indexes for COVID-19 patient risk stratification.
- To compare the diagnostic efficacy and clinical utility of individual laboratory markers and the developed prediction model.
Main Methods:
- Retrospective analysis of 170 COVID-19 patients, categorized into asymptomatic-moderate and severe or above groups.
- Multivariate logistic regression was employed to construct a prediction model based on significant laboratory indexes.
- Receiver operating characteristic (ROC) curve and Decision Curve Analysis (DCA) were used to evaluate diagnostic performance and clinical validity.
Main Results:
- Significant differences in blood cell count, high-sensitivity C-reactive protein (hsCRP), and procalcitonin (PCT) were observed between severity groups (P<0.05).
- Individual hsCRP demonstrated high diagnostic efficacy (AUC=0.870).
- The combined prediction model (red blood cell count, hsCRP, PCT) showed a higher AUC (0.912) and superior net benefit in DCA compared to individual markers.
Conclusions:
- A prediction model integrating red blood cell count, hsCRP, and PCT effectively predicts clinical classification in COVID-19 patients.
- This model offers improved clinical utility for risk stratification compared to individual laboratory indexes.
- The developed model serves as a valuable tool for assessing COVID-19 patient severity and guiding treatment decisions.
Abstract:
In the present study, a prediction model with combined laboratory indexes in risk stratification of patients with COVID-19 was established and tested. The data of 170 patients with COVID-19 who were divided into an asymptomatic-moderate group (141 cases) and severe or above group (29 cases) were retrospectively analyzed. The clinical characteristics and laboratory indexes of the two groups were compared. Multivariate logistic regression analysis was performed to construct the prediction model based on laboratory indexes. A receiver operating characteristic (ROC) curve analysis was used to compare the diagnostic efficacy of different indexes. Decision curve analysis (DCA) was performed to quantify and compare the clinical validity of the prediction models. There were significant differences in blood cell count, high-sensitivity C-reactive protein (hsCRP) and procalcitonin (PCT) levels between the severe or above group and the asymptomatic-moderate group (all P<0.05). Among all individual indexes, hsCRP had the highest diagnostic efficacy (area under the curve=0.870), with a sensitivity and specificity of 0.828 and 0.802, respectively. The red blood cell count, hsCRP and PCT were used to construct the prediction model. The AUC of the prediction model was higher than that of hsCRP (0.912 vs. 0.870) but the difference was not significant (P=0.307). DCA suggested that the net benefit of the prediction model was higher than that of hsCRP in most cases and significantly higher than that of PCT, lymphocytes and monocytes. The prediction model with combined laboratory indexes was able to more effectively predict the clinical classification of patients with COVID-19 and may be used as a tool for risk stratification of patients.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Steps in Outbreak Investigation
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Relative Risk
Cancer Survival Analysis
Statistical Methods for Analyzing Epidemiological Data

